Aptorum Group Ltd (APM)
4.83
+0.08
(+1.68%)
USD |
NASDAQ |
May 20, 16:00
4.77
-0.06
(-1.24%)
After-Hours: 20:00
Aptorum Group Shareholders Equity (Quarterly): 24.85M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 24.85M |
| June 30, 2023 | 21.84M |
| June 30, 2023 | 21.84M |
| December 31, 2022 | 15.71M |
| June 30, 2022 | 22.65M |
| June 30, 2022 | 22.65M |
| December 31, 2021 | 23.61M |
| June 30, 2021 | 31.51M |
| June 30, 2021 | 31.51M |
| Date | Value |
|---|---|
| December 31, 2020 | 41.83M |
| June 30, 2020 | 19.84M |
| June 30, 2020 | 19.84M |
| December 31, 2019 | 16.36M |
| June 30, 2019 | 24.94M |
| June 30, 2019 | 24.94M |
| December 31, 2018 | 33.11M |
| June 30, 2018 | 24.63M |
| June 30, 2018 | 24.63M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
15.71M
Minimum
Dec 2022
41.83M
Maximum
Dec 2020
24.26M
Average
22.65M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| TC BioPharm (Holdings) PLC | 1.364M |
| Renalytix PLC | -11.11M |
| Immuron Ltd | 11.94M |
| Adaptimmune Therapeutics PLC | 24.38M |
| Biodexa Pharmaceuticals Plc | 5.959M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.64M |
| Total Liabilities (Quarterly) | 5.257M |